PharmaCyte Biotech (PMCB) Return on Capital Employed [ROCE] (2009 - 2026)
PharmaCyte Biotech's Return on Capital Employed [ROCE] came in at -17.12% for fiscal Q1 2027 (quarter ended Jul 31, 2026), down 9.06 percentage points from -8.06% a year earlier and down 3.54 percentage points from the prior quarter.
Powered by 
Analysis
PharmaCyte Biotech (PMCB) Return on Capital Employed [ROCE] (2009 - 2026) Analysis & Trends
For FY2026 (ended Apr 30, 2026), PharmaCyte Biotech's Return on Capital Employed [ROCE] was -13.67%, down 5.66 percentage points from FY2025.
- Return on Capital Employed [ROCE] carries a five-year change of +46.11 percentage points (FY2021 to FY2026).
- Going back by fiscal year, Return on Capital Employed [ROCE] was -8.01% in FY2025 (+6.38 pp), -14.40% in FY2024 (-6.47 pp), -7.93% in FY2023 (+1.16 pp) and -9.09% in FY2022 (+50.69 pp).
- The fiscal Q1 2027 figure represents the lowest quarterly Return on Capital Employed [ROCE] since fiscal Q1 2022.
- Year-over-year, Return on Capital Employed [ROCE] increased in four of the last eight quarters, with an average year-over-year change of -0.49 percentage points.
- The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in fiscal Q1 2023 (a gain of 56.01 percentage points), and the weakest in fiscal Q1 2027 (a drop of 9.06 percentage points).
- Business Quant data shows PMCB's Return on Capital Employed [ROCE] at -13.58% (Q4 2026), -9.93% (Q3 2026) and -8.63% (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 35.41% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 17.52% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 21.60% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.65% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.91% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 17.37% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -6.15% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 11.32% |
| 10 | PharmaCyte Biotech | 4.29 Mn | -68.55 Mn | - | -17.12% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | -17.12% |
| Apr 30, 2026 | -13.58% |
| Jan 31, 2026 | -9.93% |
| Oct 31, 2025 | -8.63% |
| Jul 31, 2025 | -8.06% |
| Apr 30, 2025 | -9.40% |
| Jan 31, 2025 | -13.47% |
| Oct 31, 2024 | -12.80% |
| Jul 31, 2024 | -13.40% |
| Apr 30, 2024 | -14.64% |
| Jan 31, 2024 | -9.26% |
| Oct 31, 2023 | -8.01% |
| Jul 31, 2023 | -9.13% |
| Apr 30, 2023 | -8.60% |
| Jan 31, 2023 | -8.90% |
| Oct 31, 2022 | -7.62% |
| Jul 31, 2022 | -5.74% |
| Apr 30, 2022 | -4.85% |
| Jan 31, 2022 | -4.28% |
| Oct 31, 2021 | -7.75% |
API Access
PharmaCyte Biotech Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=PMCB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "PMCB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=PMCB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();